0503146 - BTÚ 2019 RIV eng P - Patent Document
Neužil, Jiří - Werner, L. - Štursa, J.
Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level.
2018. Owner: J. Neužil, Biotechnologický ústav AV ČR, v. v. i., Smart Brain s.r.o., KKCG AG. Date of the patent acceptance: 20.02.2018. Patent Number: US9896466
Institutional support: RVO:86652036
Keywords : Mitochondrial targeting * Anticancer * Respiration
OECD category: Biochemistry and molecular biology
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20180220&DB=&locale=en_EP&CC=US&NR=9896466B2&KC=B2&ND=4
Permanent Link: http://hdl.handle.net/11104/0294965
Neužil, Jiří - Werner, L. - Štursa, J.
Tamoxifen derivatives for treatment of neoplastic diseases, especially with high HER2 protein level.
2018. Owner: J. Neužil, Biotechnologický ústav AV ČR, v. v. i., Smart Brain s.r.o., KKCG AG. Date of the patent acceptance: 20.02.2018. Patent Number: US9896466
Institutional support: RVO:86652036
Keywords : Mitochondrial targeting * Anticancer * Respiration
OECD category: Biochemistry and molecular biology
https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20180220&DB=&locale=en_EP&CC=US&NR=9896466B2&KC=B2&ND=4
Permanent Link: http://hdl.handle.net/11104/0294965